The Plasma Resectoscope Market Size is valued at USD 304.13 Mn in 2023 and is predicted to reach USD 519.57 Mn by the year 2031 at a 7.05% CAGR during the forecast period for 2024-2031.
A plasma resectoscope is a surgical tool utilized in the urological subspecialty of transurethral resection of the prostate (TURP) procedures. Excess prostate tissue caused by benign prostatic hyperplasia (BPH) can be surgically removed with a plasma resectoscope, a specialized tool that employs plasma energy. Growing plasma resectoscopes incorporate state-of-the-art imaging technology.
Innovations in technology and new products that enhance the effectiveness of procedures and patient outcomes are also contributing to the expansion of the market. A constant stream of technology and product improvements. Better patient outcomes and procedural efficiency can be achieved by developing plasma resectoscope devices with increased cutting and coagulation capabilities, upgraded viewing systems, and ergonomic designs.
This trend is expected to fuel the need for plasma resectoscope devices. As a result, companies in this sector are working hard to perfect bipolar plasma technology for use in plasma resectoscopes to better serve doctors and their patients. It drives expansion globally and is expected to boost market expansion in the coming years.
However, the population growth of patients, urologists, and other qualified medical personnel is in short supply. Obtaining the necessary clearances from regulators could prove difficult for the plasma resectoscope business during the COVID-19 outbreak. It may restrain the development of the target market over the predicted time frame. As a result of the global spread of COVID-19, international trade in medical supplies has been disrupted.
The pandemic has hampered the expansion of this market because of the uncertainty and interruption in the availability of medications. Furthermore, increasing R&D activities and investments by prominent players are expected to create lucrative growth opportunities in revenue for players operating in the global plasma resectoscope market over the forecast period.
Competitive Landscape
Some Major Key Players In The Plasma Resectoscope Market:
- Olympus Corporation
- KARL STORZ SE & Co. KG
- Richard Wolf GmbH
- Stryker Corporation
- Medtronic plc
- Ethicon (Johnson & Johnson)
- Braun Melsungen AG
- Boston Scientific Corporation
- Cook Medical
- ROCAMED
- Maxer Endoscopy GmbH
- Vimex Endoscopy
- PENTAX Medical (HOYA Corporation)
- Hunan Handlike Minimally Invasive Surgery Co. Ltd.,
- Optimed Medizinische Instrumente GmbH
Market Segmentation:
The plasma resectoscope market is segmented based on product type, application, Distribution Channel, Endoscopic Visualization System Integration and end-user. The product type segment consists of implantable monopolar plasma resectoscopes and bipolar plasma resectoscopes. By application, the market is segmented into transurethral resection of the prostate (TURP), bladder tumour resection, urethral stricture resection, and others.
By the end-user segment, the market is divided into hospitals and clinics, ambulatory surgical centres, speciality clinics, and others. By Endoscopic Visualization System Integration, the market is divided as Non-integrated Plasma Resectoscope, Integrated Plasma Resectoscope. Whereas Distribution Channel segment comprises Direct Sales, Distributor Sales, Recent Developments, New product launches.
Based On Product Type, The Bipolar Plasma Resectoscope Devices Segment Is Accounted As A Major Contributor To The Plasma Resectoscope Market
The bipolar plasma resectoscope category is expected to hold a major share of the global market in 2024. It is attributed to the bipolar resectoscope has benefits over the monopolar version, including improved cut and coagulation thanks to the plasma impact of bipolar current, decreased tissue changes, less bleeding during resection, enhanced visibility, and lower cost. Additionally, surgical procedures can be simplified using bipolar plasma technology, which combines cutting and coagulation with a single tool.
The Hospital Segment Witnessed The Development At A Rapid Rate.
The hospital's segment is likely to grow at a rapid rate in the global plasma resectoscope market owing to an increase in the number of people seeking urination disease issues and the need for plasma resectoscope treatment, especially in countries such as the US, Germany, UK, China, and India.
In The Region, The North American Plasma Resectoscope Market Holds A Significant Revenue Share.
The North American Plasma plasma resectoscope market is expected to record the maximum market share in revenue in the near future. It can be attributed to the rise in BPH cases and the popularity of less-invasive treatments. Strong healthcare infrastructure, government programs emphasizing early diagnosis and treatment of urological problems, and an expanding elderly population.
In addition, the presence of key market competitors and developments in medical technology fuel expansion in the region's industries. In addition, Asia Pacific is estimated to grow rapidly in the global plasma resectoscope market because there is a big patient pool, rising healthcare costs, better healthcare facilities and growing financial support from the business and medical communities.
Plasma Resectoscope Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 304.13 Mn |
|
Revenue Forecast In 2031 |
USD 519.57 Mn |
|
Growth Rate CAGR |
CAGR of 6.9% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million, volume (units) and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, By End User, By Application, By Endoscopic Visualization System Integration, By Distribution Channel |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Olympus Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, Stryker Corporation, Medtronic plc, Ethicon (Johnson & Johnson), Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, ROCAMED, Maxer Endoscopy GmbH, Vimex Endoscopy, PENTAX Medical (HOYA Corporation), Hunan Handlike Minimally Invasive Surgery Co. Ltd., Optimed Medizinische Instrumente GmbH. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
